COMP <GO>
PARK vs CCEL // EV/EBITDA & P/E VALUATION
Park Dental Partners Inc. (NASDAQ) VS. Cryo-Cell International Inc. (NYSE) • 15-METRIC TALLY: PARK 1
— CCEL 2
■ METRIC PARITY
LAST: $20.06 (-2.79%) • MKT CAP: $95.4M
valuation
—
LAST: $5.19 (+1.17%) • MKT CAP: $41.8M
valuation
61.2x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PARK VS. CCEL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PARK | CCEL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | 18.20% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 61.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 12.55% | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 7.73% | -7.73 | CCEL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.9 | 64.3 | -6.41 | CCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.4M | $41.8M | $53.6M | PARK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PARK REV | CCEL REV | PARK GROSS % | CCEL GROSS % | PARK FCF | CCEL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | — | $5.2M |
| FY 2024 | — | $0 | — | — | — | $3.6M |
| FY 2023 | — | $0 | — | — | — | $8.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PARK // BETA —
CCEL // BETA —